A previously healthy 15-yearold male with well-controlled asthma developed pain in his right foot approximately 7 weeks prior to transfer from an outside hospital. The pain was described as "burning mixed with numbness." He was seen at an outside emergency department where X-rays were normal and he was discharged. Although the pain subsided over several days after he was discharged, it returned and started to involve the right calf. He returned to that emergency department and was admitted to the outside hospital for further evaluation. Both the patient and his father reported the pain had caused an abnormal gait; he walked on his toes with inability to fully extend the knee secondary to pain.
Review of systems was otherwise unremarkable. He has mild intermittent asthma. Family history is unremarkable.
On examination, he was sitting and resting comfortably. Pulse was 100 beats per minute, respiratory rate was 14 breaths per minute, and blood pressure was 120/82 mm Hg. His general physical exam was normal. On neurologic examination, his mental status was normal. Cranial nerves were normal. He had normal strength. Reflexes were 2+ throughout with down-going toes. Cerebellar examination was intact but limited by pain. On sensory examination, light touch and temperature were intact on the face. He had increased pain to touch on the right calf. He had decreased pain to heat and cold in the ulnar distribution of the right hand and bilateral lateral dorsal lower extremities. Proprioception and vibration were intact in the upper and lower extremities.
Robert Listernick, MD, moderator: Let me throw out a thought. Does he have reflex sympathetic dystrophy (complex regional pain syndrome)?
Leon Epstein, MD, pediatric neurologist: On the basis of history prior to the examination, that would have been a reasonable diagnosis. It would have been a better fit if he had had a history of an antecedent trauma. However, the trauma certainly could have been trivial and gone unnoticed. What fits is the exquisite sensitivity, and more importantly for complex regional pain syndrome, the fact that the pain crosses the boundaries of specific nerves. In other words, the entire foot is involved and the pain can't be localized to the peroneal nerve. Firm Rounds antidepressants had the best evidence of efficacy in adults, followed by the anticonvulsants (gabapentin, pregabalin, and carbamazepine). They found the least evidence for the selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors.
Dr. Listernick: I haven't seen tricyclic antidepressants used much lately.
Dr. Frader: These medications have fallen out of favor in pediatrics. They have the most rapid onset (days) and are the least expensive.
Dr. Listernick: What about opioids? Dr. Frader: There is conflicting evidence as to the utility of opioids in neuropathic pain. There's some evidence that methadone works best. However, methadone takes several days to develop a steady-state level and it is relatively difficult to establish the eventual dose to the patient needs. There is also some evidence that oxycodone may work a little bit better than morphine or hydromorphone. It is important to emphasize that right now we do not have ways to predict which patients will benefit from which class or combination of drugs. Dr. Epstein: If it involves the smallest pain fibers, nerve conduction studies or electromyogram won't be helpful. Specific autonomic testing can be very helpful. In his case, he was placed in a thermoregulatory sweat chamber, which is like a sauna, and covered in a powder that turns purple when exposed to sweat. He demonstrated multiple areas on the distal upper extremities and in almost the entire lower extremities where his skin didn't turn purple, indicating a lack of sweat and the presence of small fiber autonomic dysfunction.
Dr. Listernick: Moving forward, the following tests were normal: complete blood count with differential, serum chemistries, hepatic function, Firm Rounds erythrocyte sedimentation rate, hemoglobin A1C, Lyme serology, vitamin B12, antinuclear antibodies, anti-double-stranded DNA, antiribonuclear protein antibody, anti-Smith antibody, and anti-Ro and anti-LA antibodies. However, the antineutrophil cytoplasmic antibody (ANCA) was highly positive.
Megan Curran, MD, pediatric rheumatologist: Initially, to evaluate the presence of ANCA, an immunofluorescent antibody test is performed, looking for antibodies that bind the cytoplasm of a neutrophil. If positive, the next step is looking for antibodies to one of two specific antigens. In general, antibodies to PROT3 with a cytoplasmic (c-ANCA) staining pattern are seen in patients with granulomatosis with polyangiitis (formerly known as Wegener's granulomatosis), whereas antibodies to myeloperoxidase with a perinuclear (p-ANCA) staining pattern are seen in microscopic polyangitis or eosinophilic granulomatosis with polyangiitis (Churg-Strauss disease). Our patient had a p-ANCA staining pattern.
Dr. Listernick: The next step was sural nerve biopsy.
Jonathan Bush, MD, pediatric pathologist: Here's a medium-sized arteriole whose media exhibits fibrinoid necrosis with intimal thickening. There are inflammatory cells extending through the intima into the dead media. There's a thrombus forming within the lumen of the vessel. The vasculature of the vasa nervorum (the blood vessels that supply the nerves) shows similar features. The combination of pathologic features coupled with the serology is diagnostic of Churg-Strauss disease.
Dr. Listernick: Apparently, mononeuritis multiplex is a classic presentation of Churg-Strauss vasculitis. Who knew?
Dr. Klein-Gitelman: More than 90% of patients with Churg-Strauss disease have asthma for as long as 10 years before diagnosis of vasculitis. The literature describes cases of patients whose asthma is well-controlled on inhaled steroids who have the sudden appearance of vasculitis if steroids are stopped. As in other vasculitides, multiorgan involvement is common, including endomyocardial involvement, vasculitic skin lesions (in particular tender subcutaneous nodules), glomerulonephritis, eosinophilic gastroenteritis, and, of course, mononeuritis multiplex. He had a history of asthma but had a normal chest X-ray and computed tomography scan of the sinuses. Dr. Listernick: The only problem, as I understand it, is that the father refused treatment with steroids.
Dr. Curran: Yes, he's a strong believer in natural remedies and he wanted to treat him with ginger and curcumin, an ingredient of turmeric.
Dr. Listernick: So how far do you go in letting families dictate treatment?
Elaine Morgan, MD, pediatric oncologist: Your first line of defense should be always to negotiate. The last thing you want to do is take this into court and alienate the family, make life difficult for the child or the practitioner, and take a chance on having a judge who doesn't understand the gravity of the situation. One can negotiate for as long as you don't compromise the well-being of the child.
Dr. Frader: I agree, but we have to understand that this child needed therapy immediately in order to avoid the risk of permanent neurologic damage.
Dr. Epstein: In fact, there is a significant chance of mortality if left untreated.
Dr. Curran: The father was allowing the pain medications because he was very concerned about his son's pain. But he was equally adamant about the fact that natural treatments will reduce inflammation significantly and didn't want the steroids.
Kristine Fortin, MD, MPH, protective services team physician: By the time I became involved, the team had done an excellent job and all of the hard work had already been done. One of the key things in a case like this is documentation. It's extremely important to document what you've told the parents about the diagnosis, the consequences of the disease, the Key Learning Points 1. Children who have reflex sympathetic dystrophy (complex regional pain syndrome) have exquisite sensitivity and pain that crosses the boundaries of specific nerves (eg, an entire foot or extremity).
2. There is very little systemic evidence regarding the control of neuropathic pain in children.
Extrapolating from adult data, tricyclic antidepressants have the best evidence of efficacy followed by the anticonvulsants (gabapentin, pregabalin, and carbamazepine) and finally the selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors.
3. Mononeuritis multiplex is a painful, asymmetric, sensory, and motor peripheral neuropathy involving damage to at least two separate nerve areas. Dr. Fortin: He was very intelligent and knew that he was benefitting from the pain medication. He didn't really understand the prednisone treatment but wanted it if "it would make him better." Dr. Listernick: So he's now receiving gabapentin and prednisone. Prognosis?
Dr. Curran: The steroids are reducing the inflammation. I'm concerned about what will happen to his pain when I start to reduce the dose. There's no specific laboratory testing to use as an indicator of disease activity; I may have to use recrudescence of pain as the best indicator.
Dr. Listernick: Thanks everyone.
